Literature DB >> 21474480

Levofloxacin weight-adjusted dosing and pharmacokinetic disposition in a morbidly obese patient.

Sonia Luque, Santiago Grau, Marta Valle, Clara Isabel Colino, Antoni Ferrer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21474480     DOI： 10.1093/jac/dkr146

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Therapeutic Drug Monitoring of Levoffoxacin in an Obese Adolescent: A Case Report.

Authors:  Alexandra M Hanretty; Wayne S Moore; Arun Chopra; Jeffrey J Cies
Journal:  J Pediatr Pharmacol Ther       Date:  2020

Review 2.  Antibiotic therapy of pneumonia in the obese patient: dosing and delivery.

Authors:  Hasan M Al-Dorzi; Shmylan A Al Harbi; Yaseen M Arabi
Journal:  Curr Opin Infect Dis       Date:  2014-04       Impact factor: 4.915

Review 3.  Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns.

Authors:  Chu-Han Gao; Lu-Shan Yu; Su Zeng; Yu-Wen Huang; Quan Zhou
Journal:  Ther Clin Risk Manag       Date:  2014-03-27       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.